Made from proprietary Hyper-crosslinked Carbohydrate Polymer (HCCP) material, this suture is designed for internal soft tissue repair such as ligament and tendon closure. It dissolves gradually with minimal inflammation, supporting natural healing.

The product addresses a $1.5 billion market and offers a strong alternative to synthetic polymer sutures. Prototyping and feasibility studies are complete, with preclinical data showing promising results in suturability, tissue response, and mechanical strength.

Projected peak sales are $100 million annually.